PIK3CA and Hyperglycemia: We report the case of a severe hyperglycemia associated with alpelisib treatment in a patient with metastatic breast cancer, which highlights PI3K inhibitor pharmacodynamic aspects, its influence in glycemic control and the required treatment approach.